- Viral Infections and Immunology Research
- IL-33, ST2, and ILC Pathways
- Cardiovascular Effects of Exercise
- Heart Failure Treatment and Management
- Cardiovascular Function and Risk Factors
- Acute Myocardial Infarction Research
- Cardiomyopathy and Myosin Studies
- Oral Health Pathology and Treatment
- Phytochemical and Pharmacological Studies
- Inflammasome and immune disorders
Fudan University
2020-2025
Zhongshan Hospital
2020-2025
Shanghai Institute of Hematology
2020
The First Affiliated Hospital, Sun Yat-sen University
2020
Sun Yat-sen University
2020
Background and purpose: With the implementation of Chest Pain Centers program, significant advancements have been achieved in managing risk factors providing coronary interventional treatments China. However, a notable gap exists understanding occurrence de novo heart failure (HF) following ST-segment elevation myocardial infarction (STEMI). This study aimed to describe incidence, clinical characteristics, related factors, prognostic significance HF after STEMI contemporary Methods: cohort...
BACKGROUND: Arrhythmogenic right ventricular cardiomyopathy (ARVC) is an inherited heart disease characterized by irregular rhythms and dysplasia. Sequence variations in desmosomal protein-encoding genes are linked to ARVC development. Effective treatments for lacking. Whereas mRNA-based therapies have shown efficacy humans, their therapeutic potential cardiomyopathies remains unclear. METHODS: Whole-exome sequencing identified a novel DSC2 sequence variation causing autosomal recessive...